Submission of Nidlegy marketing authorisation application validated by EMA EP News Bureau Jul 4, 2024 The first marketing authorisation application of Nidlegy for the treatment of locally advanced fully resectable melanoma was…
China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData EP News Bureau May 29, 2023 HTIT has recently submitted a marketing authorisation application in China for first oral insulin for type 2 diabetes
